EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma S100A8 and S100A9 Are Strong Prognostic Factors for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure

Yao Zhang iD, Xueyun Zhang iD, Jiajia Han iD, Yifei Guo iD, Jingjing He iD, Feifei Yang iD, Richeng Mao iD, Yuxian Huang iD, Jiming Zhang iD

Canadian Journal of Gastroenterology and Hepatology · 2023

DOI: 10.1155/2023/6164611 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Gastroenterology and Hepatology, 2023. Verfasst von Yao Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Shanghai Institute of Infectious …. Hauptthemen laut MEDLINE: Acute-On-Chronic Liver Failure, Hepatitis B, Chronic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fudan University, Shanghai Municipal Science and Technology Major Project, Shanghai Shen Kang Hospital Development Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The rapidly evolving organ failure and high short-run mortality of acute-on-chronic liver failure (ACLF) are inseparable from the role of systemic inflammatory response. S100A8 and S100A9 are associated with the excessive cytokine storm and play a decisive part within the process of inflammation. We aimed to clarify the role of them in predicting prognosis of hepatitis B virus-related ACLF (HBV-ACLF).

Methods

S100A8 and S100A9 levels were analyzed in plasma of 187 transplant-free HBV-ACLF patients, 28 healthy controls and 40 chronic hepatitis B (CHB) patients. S100A8 and S100A9 mRNAs were checked in liver samples from 32 HBV-ACLF patients with liver transplantation, 19 patients undergoing surgery for hepatic hemangioma and 10 CHB patients with needle biopsy.

Results

The plasma levels of the S100A8 and S100A9 were higher in HBV-ACLF patients than in CHB patients (S100A8 : P < 0.001 and S100A9 : P < 0.001 ) and healthy controls (S100A8 : P < 0.001 and S100A9 : P < 0.001 ), and similar results were obtained for mRNA expression. Moreover, both proteins were related to ACLF grade, different types of organ failure, and infection, and they correlated with other prognostic scoring systems. S100A8 and S100A9 can dependently predict 28/90-day mortality (28-day: S100A8: hazard ratio (HR): 1.027; 95% confidence interval (CI): 1.007–1.048; P = 0.026 , S100A9 : HR: 1.009; 95% CI: 1.001–1.017; P = 0.007 , 90-day: S100A8 : HR: 1.023; 95% CI: 1.011–1.035; P = 0.004 , S100A9 : HR: 1.008; 95% CI: 1.004–1.012; and P < 0.001 ). Among all of the scoring systems, the combined scoring model (S100A8 and S100A9 jointly with the Chronic Liver Failure-Consortium Organ Failure score (CLIF-C OFs)) displayed the highest area under the receiver operating curve (0.923 (95% CI, 0.887–0.961)) in the prediction of 90-day mortality.

Conclusions

S100A8 and S100A9 are promising biomarkers for the analysis of risk stratification and prognosis in ACLF patients. In addition, combining them with the CLIF-C OFs may better predict the prognosis of ACLF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute-On-Chronic Liver FailureHepatitis B, ChronicHumansBiomarkersHepatitis B virusOrgan Dysfunction ScoresPrognosisRetrospective StudiesROC CurveCalgranulin ACalgranulin B

Substanzen

BiomarkersS100A8 protein, humanCalgranulin AS100A9 protein, humanCalgranulin B

Autor:innen und Institutionen

  • Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Shanghai Institute of Infectious Diseases and Biosecurity, National Medical Center for Infectious Disea…
  • Department of Hepatitis Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Frontiers Science Center of Pathogenic Microorganisms and Infection, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Sh…

ORCID-Profile: Yao Zhang, Xueyun Zhang, Jiajia Han, Yifei Guo, Jingjing He, Feifei Yang, Richeng Mao, Yuxian Huang, Jiming Zhang

Förderung

  • Fudan University
  • Shanghai Municipal Science and Technology Major Project
  • Shanghai Shen Kang Hospital Development Center
  • Shanghai Key Clinical Specialty Construction Program

Zitieren

APA

Zhang, Y., Zhang, X., Han, J., Guo, Y., He, J., Yang, F., Mao, R., Huang, Y., & Zhang, J. (2023). Plasma S100A8 and S100A9 Are Strong Prognostic Factors for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Canadian Journal of Gastroenterology and Hepatology. https://doi.org/10.1155/2023/6164611

Vancouver

Zhang Y, Zhang X, Han J, Guo Y, He J, Yang F, et al. Plasma S100A8 and S100A9 Are Strong Prognostic Factors for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Canadian Journal of Gastroenterology and Hepatology. 2023. doi:10.1155/2023/6164611

BibTeX
@article{Zhang2023,
  author = {Zhang, Yao and Zhang, Xueyun and Han, Jiajia and Guo, Yifei and He, Jingjing and Yang, Feifei and Mao, Richeng and Huang, Yuxian and Zhang, Jiming},
  title = {Plasma S100A8 and S100A9 Are Strong Prognostic Factors for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure},
  journal = {Canadian Journal of Gastroenterology and Hepatology},
  year = {2023},
  doi = {10.1155/2023/6164611}
}
Kostenlos starten →